Skip to Main Content

Paper Details

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients.
Science
674
2021
-expressing myeloid cells, CD8+, CD8+ T cell, PD-1, PD-1-refractory, advanced melanoma, anti-PD-, anti-PD-1, cancer, interleukin-8, interleukin-8-expressing myeloid cells, melanoma, patients, programmed cell death protein 1, tumor
Author NameAffiliation
Amiran DzutsevCenter for Cancer Research, National Cancer Institute
John A McCullochCenter for Cancer Research, National Cancer Institute
Jonathan H BadgerCenter for Cancer Research, National Cancer Institute
Ivan Vujkovic-CvijinNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
Yasmine BelkaidNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
Yasmine BelkaidNational Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health
John M KirkwoodDepartment of Medicine and UPMC Hillman Cancer Center, University of Pittsburgh
Giorgio TrinchieriCenter for Cancer Research, National Cancer Institute
Giorgio TrinchieriCenter for Cancer Research, National Cancer Institute
  • 1 - 9

Datasets

Release 1.2